Polyethylene glycol bovine hemoglobin conjugate (Beijing Kaizheng Biotech Development)
聚乙二醇牛血红蛋白偶联物（北京凯正生物）
Report date: 2022/07/15 15:12:26
Base Information
Drug NamePolyethylene glycol bovine hemoglobin conjugate (Beijing Kaizheng Biotech Development)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesBeijing Kaizheng Biotech Developing Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesBeijing Kaizheng Biotech Developing Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A